A heartfelt thank you to our staff for their dedication and teamwork. We are grateful for your hard work, planning, and solution-oriented thinking which drive #GBMAGILE forward each day. Thank you to our staff past and present, collaborators, partners, and vendors for your commitment to innovation, learning, and progress for patients. We are #FasterTogether!
Global Coalition for Adaptive Research
Research
Larkspur, CA 8,132 followers
Accelerating the discovery and development of treatments for patients with rare and deadly diseases
About us
The Global Coalition for Adaptive Research (GCAR) unites physicians, clinical researchers, advocacy and philanthropic organizations, biotech/pharma, health authorities, and other key stakeholders in healthcare to expedite the discovery and development of treatments for patients with rare and deadly diseases. As Sponsor of innovative trials, including master protocols and adaptive platform trials, GCAR is dedicated to the advancement of science by modernizing clinical trials that support more efficient, less costly drug development. Adaptive platform trials deliver an unmatched accelerated time from discovery in the lab to implementation in the clinic resulting in better treatments and lives saved.
- Website
-
http://www.gcaresearch.org
External link for Global Coalition for Adaptive Research
- Industry
- Research
- Company size
- 11-50 employees
- Headquarters
- Larkspur, CA
- Type
- Nonprofit
- Founded
- 2017
- Specialties
- Adaptive Platform Trials, Glioblastoma GBM, Development of Cures for Patients with Rare and Deadly Diseases, Cancer Research, Cancer Policy, Clinical Trials, Cancer Treatment, Patient Information, Medical Research and Development, Funding Innovative Brain Cancer Research, Global Research Collaboration, Fundraising, and Advocacy
Locations
-
Primary
Get directions
Larkspur, CA 94939, US
Employees at Global Coalition for Adaptive Research
-
Faramarz Yousefzadeh
WattEV, Canon Equity, GCAR, and Windmill Capital
-
Web Cavenee
Director Emeritus at Ludwig Institute; Professor at UCSD
-
Ashley A. Powell PhD
Vice President, Trial Operations at Global Coalition for Adaptive Research
-
Matthew Viva
Director, Legal at Global Coalition for Adaptive Research
Updates
-
Over the last five years #GBMAGILE, a first of its kind clinical trial for patients with #glioblastoma, has achieved significant milestones through the collaborative efforts of numerous individuals, ongoing support from partnerships, and a community driven to improve treatment options. We are #fastertogther, united and determined to maximize learning from every patient; we will continue to make progress in our fight against GBM.
-
Celebrating 5 years of impact of GBM AGILE #FasterTogether
-
-
Celebrating 5 years of impact of GBM AGILE #FasterTogether
-
-
Celebrating 5 years of impact of GBM AGILE #FasterTogether
-
-
Celebrating 5 years of impact of GBM AGILE #FasterTogether
-
-
Celebrating 5 years of impact of GBM AGILE #FasterTogether
-
-
Celebrating 5 years of impact of GBM AGILE #FasterTogether
-
-
Celebrating 5 years of impact of GBM AGILE #FasterTogether
-
-
Celebrating 5 years of impact of GBM AGILE #FasterTogether
-